PHILADELPHIA, Feb. 1, 2013 /PRNewswire/ -- George Bessenyei, Gregory V. Novak, and Robert S. Goggin (the "Group") today launched their website, www.savevrml.com, to provide all stockholders access to relevant information concerning Vermillion Inc.'s (the "Company" or "Vermillion") contested 2012 Annual Stockholder meeting (the "2012 Annual Meeting").
The road to forcing Vermillion's Board to schedule the annual meeting has been anything but easy, short, or smooth. Almost a year ago, on February 15, 2012, the Group announced its intention to nominate Robert S. Goggin as Director Nominee for the 2012 Annual Meeting. After a series of dodge ball tactics by the Board and Gail Page, more recently, on January 9, 2013, Bessenyei filed a complaint in the Delaware Chancery Court ("Court"), asking the Court to order the Company to call and hold an annual meeting of stockholders at the earliest practicable date. This maneuver was necessary, given what the Group believes was management's stonewalling, to finally force the Company to abide by its own Bylaws, Delaware law and to avoid a NASDAQ delisting process, and call the 2012 meeting. After the complaint was filed, the Company finally set the meeting date for March 21st, 2013.
In order to provide more information to stockholders, the Group today launched its website. Major topics include:
- Robert S. Goggin's Five Point Turnaround Plan for Vermillion
- Comprehensive analysis of OVA1 and its market potential
- Biography of Group members
- Timeline of events leading to the 2012 Annual Meeting
- Compensation counter tracking the benefits provided to Vermillion Directors over the past several years, currently standing at a staggering $13,176,632
- The Reverse Midas Touch: Chairman James S. Burns' track record at public companies*
Visit our webpage today!
The Group's proxy statement (the "Group Proxy Statement"), filed on January 29, 2013, is available free of charge at www.sec.gov. The Group Proxy Statement will first be sent or given to stockholders on or about February 6, 2013. Stockholders are advised to read the Group Proxy Statement and the other documents relating to the Group's solicitation of proxies by members of the Group from stockholders of the Company for use at its 2012 Annual Meeting because they contain important information.
*(James S. Burns serves as Chairman of the Board at Vermillion; he is also a Director at Symmetry Medical, Inc. and Chief Executive Officer at AssureRx Health, Inc.)
Stockholders please contact Okapi Partners LLC
Patrick McHugh / Geoff Sorbello
Concerned Vermillion Stockholders
SOURCE Concerned Vermillion Stockholders